medroxyprogesterone acetate has been researched along with Fever in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mani, S; Poo, WJ | 1 |
1 review(s) available for medroxyprogesterone acetate and Fever
| Article | Year |
|---|---|
Single institution experience with recombinant gamma-interferon in the treatment of patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Renal Cell; Cohort Studies; Disease Progression; Fatigue; Female; Fever; Humans; Injections, Intravenous; Interferon-gamma; Kidney Neoplasms; Leukopenia; Male; Medroxyprogesterone Acetate; Middle Aged; Nausea; Recombinant Proteins; Remission Induction; Survival Rate; Vomiting | 1996 |
1 trial(s) available for medroxyprogesterone acetate and Fever
| Article | Year |
|---|---|
Single institution experience with recombinant gamma-interferon in the treatment of patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Renal Cell; Cohort Studies; Disease Progression; Fatigue; Female; Fever; Humans; Injections, Intravenous; Interferon-gamma; Kidney Neoplasms; Leukopenia; Male; Medroxyprogesterone Acetate; Middle Aged; Nausea; Recombinant Proteins; Remission Induction; Survival Rate; Vomiting | 1996 |